Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2208237rdf:typepubmed:Citationlld:pubmed
pubmed-article:2208237lifeskim:mentionsumls-concept:C0011854lld:lifeskim
pubmed-article:2208237lifeskim:mentionsumls-concept:C0152025lld:lifeskim
pubmed-article:2208237lifeskim:mentionsumls-concept:C0439793lld:lifeskim
pubmed-article:2208237lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:2208237lifeskim:mentionsumls-concept:C0021149lld:lifeskim
pubmed-article:2208237lifeskim:mentionsumls-concept:C0392760lld:lifeskim
pubmed-article:2208237pubmed:issue32lld:pubmed
pubmed-article:2208237pubmed:dateCreated1990-11-21lld:pubmed
pubmed-article:2208237pubmed:abstractText194 type I diabetics were subjected to neurological and electromyographic examinations. In 161 patients, i.e. in 83%, signs of polyneuropathy were detected, the severity of which was evaluated according to a 5-grade scale where grade 1 was the mildest and the 5th grade the most severe one. The authors proved a statistically significant correlation of the incidence and severity of polyneuropathy and the duration of diabetes. It was found that the decisive period of persistence of diabetes was 6-10 years. During this period the incidence of polyneuropathies increased from 30 to 87%. After 20 years duration of diabetes there was not only a 100% incidence of polyneuropathy, but severe affections--grade 3-5--predominated in 78%. In patients with severe grades of polyneuropathy diabetes was manifested at a significantly lower age than in patients without polyneuropathy and with a milder affection. The authors did not detect a significant relationship between the height of the patients and the incidence of polyneuropathy nor significant differences between men and women.lld:pubmed
pubmed-article:2208237pubmed:languageczelld:pubmed
pubmed-article:2208237pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2208237pubmed:citationSubsetIMlld:pubmed
pubmed-article:2208237pubmed:statusMEDLINElld:pubmed
pubmed-article:2208237pubmed:monthAuglld:pubmed
pubmed-article:2208237pubmed:issn0008-7335lld:pubmed
pubmed-article:2208237pubmed:authorpubmed-author:BartonSSlld:pubmed
pubmed-article:2208237pubmed:authorpubmed-author:SkibováJJlld:pubmed
pubmed-article:2208237pubmed:authorpubmed-author:VondrováHHlld:pubmed
pubmed-article:2208237pubmed:issnTypePrintlld:pubmed
pubmed-article:2208237pubmed:day10lld:pubmed
pubmed-article:2208237pubmed:volume129lld:pubmed
pubmed-article:2208237pubmed:ownerNLMlld:pubmed
pubmed-article:2208237pubmed:authorsCompleteYlld:pubmed
pubmed-article:2208237pubmed:pagination1004-8lld:pubmed
pubmed-article:2208237pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2208237pubmed:meshHeadingpubmed-meshheading:2208237-...lld:pubmed
pubmed-article:2208237pubmed:meshHeadingpubmed-meshheading:2208237-...lld:pubmed
pubmed-article:2208237pubmed:meshHeadingpubmed-meshheading:2208237-...lld:pubmed
pubmed-article:2208237pubmed:meshHeadingpubmed-meshheading:2208237-...lld:pubmed
pubmed-article:2208237pubmed:meshHeadingpubmed-meshheading:2208237-...lld:pubmed
pubmed-article:2208237pubmed:meshHeadingpubmed-meshheading:2208237-...lld:pubmed
pubmed-article:2208237pubmed:meshHeadingpubmed-meshheading:2208237-...lld:pubmed
pubmed-article:2208237pubmed:meshHeadingpubmed-meshheading:2208237-...lld:pubmed
pubmed-article:2208237pubmed:year1990lld:pubmed
pubmed-article:2208237pubmed:articleTitle[Factors affecting the incidence and severity of polyneuropathy in type I diabetes mellitus].lld:pubmed
pubmed-article:2208237pubmed:affiliationKatedra neurologie, Institutu pro dalsí vzd?lávání lékar? a farmaceut?, Praha.lld:pubmed
pubmed-article:2208237pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2208237pubmed:publicationTypeEnglish Abstractlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2208237lld:pubmed